DJ Vertex Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Vertex Pharmaceuticals Inc. $(VRTX)$ shed 2.12% to $546.12 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.38% to 7,718.60 and Dow Jones Industrial Average falling 0.51% to 53,414.25.
The stock's fall snapped a four-day winning streak.
Vertex Pharmaceuticals Inc. closed 2.52% short of its 52-week high of $560.25, which the company reached on September 3rd.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as AbbVie Inc. $(ABBV)$ fell 1.44% to $256.46, Krystal Biotech Inc. (KRYS) fell 3.56% to $358.24, and Arcturus Therapeutics Holdings Inc. $(ARCT)$ rose 1.67% to $15.82.
Trading volume (801,522) remained 695,470 below its 50-day average volume of 1.5 M.
Data source: Dow Jones Market Data, FactSet. Data compiled September 4, 2026.